| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/04/2007 | US7265109 Thiazole derivatives |
| 09/04/2007 | US7265108 For example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 09/04/2007 | US7265102 Substituted pyrazoles |
| 09/04/2007 | CA2297911C Substituted 6-phenylphenanthridines |
| 09/04/2007 | CA2116238C Oral 1 .alpha.-hydroxyprevitamin d |
| 08/30/2007 | WO2007098106A2 Respiratory tract delivery of interferon-tau |
| 08/30/2007 | WO2007096588A1 Salt of cd 80 antagonist |
| 08/30/2007 | WO2007096471A1 Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors |
| 08/30/2007 | WO2007095851A1 Unsaturated 5-member heterocycle compounds, uses and preparation methods theirof |
| 08/30/2007 | WO2007073303A3 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 08/30/2007 | WO2007050643A3 Compositions and their uses for gene therapy of bone conditions |
| 08/30/2007 | WO2007036802A3 Sublingual dosage form comrising vitamin d analogue, in particular calcitriol |
| 08/30/2007 | WO2006063837A8 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 08/30/2007 | US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/30/2007 | US20070203230 Novel Tricyclic Spiroderivatives as Modulators of Chemokine Receptor Activity |
| 08/30/2007 | US20070203229 Novel Tricyclic Spiroderivatives as Modulators of Chemokine Receptor Activity |
| 08/30/2007 | US20070203141 Method for administering birb 796 bs |
| 08/30/2007 | US20070203138 Novel Compounds and Compositions as Cathepsin S Inhibitors |
| 08/30/2007 | US20070202198 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors biofilters and bioreactors |
| 08/30/2007 | US20070202197 PAWPAW and/or peach derived composition |
| 08/30/2007 | US20070202178 Drug delivery matrices to enhance wound healing |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 08/30/2007 | US20070202099 Antibody Drug |
| 08/30/2007 | CA2643668A1 Salt of cd 80 antagonist |
| 08/30/2007 | CA2638803A1 Modulation of bone formation |
| 08/30/2007 | CA2618741A1 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 08/29/2007 | EP1826218A1 Antihuman baff antibody |
| 08/29/2007 | EP1826207A1 Acid salt of benzimidazole derivative and crystal thereof |
| 08/29/2007 | EP1826205A1 Novel raloxifene succinic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these |
| 08/29/2007 | EP1825861A2 Anti-inflammatory extract and agent and method for the production thereof |
| 08/29/2007 | EP1825858A1 Composition for promoting osteogenesis and increasing bone mineral content |
| 08/29/2007 | EP1824882A1 Osteoprotegerin variant proteins |
| 08/29/2007 | EP1824843A2 Inhibitors of protein kinases |
| 08/29/2007 | EP1824838A1 Novel compounds |
| 08/29/2007 | EP1556041B1 New crystalline hydrates of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid |
| 08/29/2007 | EP1450847A4 Apo2 ligand/trail formulations |
| 08/29/2007 | EP1425019B1 Pharmaceutical composition comprising an androgen |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 08/29/2007 | EP1259120B1 Method for isolating collagen from marine sponge and producing nanoparticulate collagen, and the use thereof |
| 08/29/2007 | EP1165781B1 Protease resistant flint analogs |
| 08/29/2007 | EP1140078B1 Benzimidazole vascular damaging agents |
| 08/29/2007 | EP0935657B1 Modified steroid hormone receptors |
| 08/29/2007 | CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 08/29/2007 | CN101027063A Preventive and/or therapeutic agent for calcipenia |
| 08/29/2007 | CN101024654A Novel polymorphs and pseudopolymorphs of risedronate sodium |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/29/2007 | CN101024050A Medicine composition for treating rheumatism and rheumatoid arthritis |
| 08/29/2007 | CN101024044A Medicine for conervation therapy of necrosis of femur head and preparing method |
| 08/29/2007 | CN101024029A Medicine for treating bony arthritis, rheumatism arthritis |
| 08/29/2007 | CN101024027A Plaster for treating rheumatism bone disease and its preparing |
| 08/29/2007 | CN101024023A Medicine for treating cervical spondylosis |
| 08/29/2007 | CN101024015A Caroprocaprae Gutturosae, ginseng, lycium extract for treating scapulohumeral periarthritis, arthromyodynia, impotence, prospermia and sub-health |
| 08/29/2007 | CN101024003A Medicine for treating injury and preparing method |
| 08/29/2007 | CN101023994A Medicinal liquor for treating rheumatism and rheumatoid diseases |
| 08/29/2007 | CN101023982A Medicine composition for treating osteoporosis |
| 08/29/2007 | CN101023981A Use of total flavone of lamiophlomis rotata leaf-stem in preparing medicine for promoting healing of bone fracture |
| 08/29/2007 | CN101023980A Use of total flarone of lamiophlomis rotata leave-stem for preparing medicine of promoting healing of bone-fracture |
| 08/29/2007 | CN101023965A Use of eupolyphaga seu steleophaga for use in medicine for treating protrusion of intervertebral disc and hyperosteogeny, its products and preparing method |
| 08/29/2007 | CN101023962A Western-chinese medicine compounded preparation for treating gout |
| 08/29/2007 | CN100334109C GLP-1 analogues |
| 08/29/2007 | CN100334106C Synthesis of cyclosporin analogs |
| 08/29/2007 | CN100334083C Piperidine derivatives as CCR5 inhibitors |
| 08/29/2007 | CN100333768C Chinese medicine extract for preventing female involutional syndrome or osteoporosis |
| 08/29/2007 | CN100333758C Gout resisting Chinese medicine composition and its prepn. process |
| 08/29/2007 | CN100333738C Chinese medicinal ointment for treating bone diseases |
| 08/28/2007 | US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1 |
| 08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 08/28/2007 | US7262199 Tyrosine kinase inhibitors |
| 08/28/2007 | US7262193 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
| 08/28/2007 | US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor |
| 08/23/2007 | WO2007095286A2 AQUEOUS PHARMACEUTICAL FORMULATIONS OF ERβ SELECTIVE LIGANDS |
| 08/23/2007 | WO2007094360A1 Process for producing polysaccharide from coffee bean or/and coffee extraction residue |
| 08/23/2007 | WO2007094193A1 Anti-angiogenic agent, prophylactic or therapeutic agent for disease accompanied by angiogenesis, and food |
| 08/23/2007 | WO2007093806A1 Dissolution aids for oral peptide delivery comprising a biguanide |
| 08/23/2007 | WO2007093431A1 A method for osteogenic differentiation of bone marrow stem cells (bmsc) and uses thereof |
| 08/23/2007 | WO2007093226A1 Oral ibandronate formulations |
| 08/23/2007 | WO2007093220A1 Use of insulin-like factor 3 for treating osteoporosis and bone disorders |
| 08/23/2007 | WO2007093183A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 08/23/2007 | WO2007093042A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | WO2007066068A3 Calcium ion channel receptor antagonist |
| 08/23/2007 | WO2007059136A3 Rankl antibody-pth/pthrp chimeric molecules |
| 08/23/2007 | US20070197629 Indole derivative and application thereof |
| 08/23/2007 | US20070197602 Combined pharmaceutical composition |
| 08/23/2007 | US20070197570 Indanol derivative |
| 08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
| 08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |
| 08/23/2007 | US20070197542 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | US20070197499 Pharmaceutical compounds |
| 08/23/2007 | US20070197465 Hyaluronic Acid-Methotrexate Conjugate |
| 08/23/2007 | US20070197450 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 08/23/2007 | US20070197449 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 08/23/2007 | US20070197434 Theurapeutic or prophyiactic agent for arthritis |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | DE102005062417A1 Kompositionen mit spezifischen und unspezifischen Lipidantagonisten Compositions with specific and nonspecific lipid antagonists |
| 08/23/2007 | CA2822302A1 Methods of impairing osteoclast differentiation |
| 08/23/2007 | CA2645734A1 Method of treating inflammatory diseases |